Skip to main content
Livermore
Livermore
ZHEN

TradeLink Capital LLC

SEC CIK
0001642044
Latest filing
Aug 5, 2026

The latest 13F from TradeLink Capital LLC covers Q2 2026 (filed Aug 5, 2026): 21 long positions worth $10.2M. The top 10 holdings make up 65.9% of the portfolio, and the largest is Zebra Technologies Corp (ZBRA) at 10.0%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
14
Est. +$6.74M
Added
4
Est. +$591.0K
Reduced
3
Est. −$838.8K
Sold out
18
Est. −$10.1M

Top 5 holdings

Share of this quarter's portfolio value

  1. ZBRAZebra Technologies Corp
    10.0%$1.02MHistory
  2. SLGNSilgan Holdings Inc
    8.0%$818.0KHistory
  3. VSECVse Corp
    7.6%$771.0KHistory
  4. GXOGXO Logistics, Inc.
    7.6%$770.0KHistory
  5. ESABESAB Corp
    7.2%$729.0KHistory

Share of portfolio

Top 5 holdings and the other 16 positions, by share of portfolio value

  1. ZBRA10.0%
  2. SLGN8.0%
  3. VSEC7.6%
  4. GXO7.6%
  5. ESAB7.2%
  6. Other 16 positions59.6%

Biggest buys

New and added positions, by estimated amount bought

  1. ZBRAZebra Technologies Corp
    +$1.02MNewHistory
  2. SLGNSilgan Holdings Inc
    +$818.0KNewHistory
  3. VSECVse Corp
    +$771.0KNewHistory
  4. ESABESAB Corp
    +$729.0KNewHistory
  5. APGAPi Group Corp
    +$579.0KNewHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ZBRAZebra Technologies Corp
    +10.01 pp0.0% → 10.0%History
  2. SLGNSilgan Holdings Inc
    +8.04 pp0.0% → 8.0%History
  3. VSECVse Corp
    +7.58 pp0.0% → 7.6%History
  4. ESABESAB Corp
    +7.16 pp0.0% → 7.2%History
  5. APGAPi Group Corp
    +5.69 pp0.0% → 5.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. TECHBIO-TECHNE Corp
    −$1.74MSold outHistory
  2. WSOWatsco Inc
    −$1.14MSold outHistory
  3. LKQLKQ Corp
    −$792.0KSold outHistory
  4. CHWYChewy, Inc.
    −$704.0KSold outHistory
  5. ENVAEnova International, Inc.
    −$700.0KSold outHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. TECHBIO-TECHNE Corp
    −13.12 pp13.1% → 0.0%History
  2. WSOWatsco Inc
    −8.59 pp8.6% → 0.0%History
  3. LKQLKQ Corp
    −5.99 pp6.0% → 0.0%History
  4. CHWYChewy, Inc.
    −5.32 pp5.3% → 0.0%History
  5. ENVAEnova International, Inc.
    −5.29 pp5.3% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$10.2M
−$3.06M (−23.1%) vs. prior quarter
Positions
21
−4 vs. prior quarter
Top 10 concentration
65.9%
Top 10 as share of value
Turnover
62.6%
Q2 2026, one quarter
Average holding period
1.5 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $34.7M (Q2 2024)

Q1 2021: $7.32MQ2 2021: $3.71MQ3 2021: $11.5MQ4 2021: $527.0KQ1 2022: $11.9MQ2 2022: $4.46MQ3 2022: $5.36MQ4 2022: $4.64MQ1 2023: $6.11MQ2 2023: $3.24MQ3 2023: $3.23KQ4 2023: $7.12MQ1 2024: $6.74MQ2 2024: $34.7MQ3 2024: $1.99MQ4 2024: $10.1MQ1 2025: $16.2MQ2 2025: $28.2MQ3 2025: $12.8MQ4 2025: $12.5MQ1 2026: $13.2MQ2 2026: $10.2M
Q1 2021Q2 2026
13F filings of TradeLink Capital LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 5, 202621$10.2MZBRASLGNVSECvs. Q1 2026SEC
Q1 2026May 13, 202625$13.2MTECHWSOLKQvs. Q4 2025SEC
Q4 2025Feb 4, 202627$12.5MWMTTECHiShares Trvs. Q3 2025SEC
Q3 2025Nov 3, 202529$12.8MHOODGWLYvs. Q2 2025SEC
Q2 2025Aug 13, 202543$28.2MiShares Russell Mid-Cap Growth ETFPLTRGOOGvs. Q1 2025SEC
Q1 2025May 8, 202537$16.2MMETAiShares Russell Mid-Cap Value ETFGOOGLvs. Q4 2024SEC
Q4 2024Feb 7, 202526$10.1MIPBRKRHAEvs. Q3 2024SEC
Q3 2024Nov 12, 20241$1.99MIPvs. Q2 2024SEC
Q2 2024Aug 8, 202485$34.7MPNRCRWDAPOvs. Q1 2024SEC
Q1 2024May 13, 202421$6.74MCRHSNXSOLVvs. Q4 2023SEC
Q4 2023Feb 13, 202413$7.12MInvesco Exch Traded FD Tr IILINCVSAvs. Q3 2023SEC
Q3 2023Nov 9, 20232$3.23KNEMATVIvs. Q2 2023SEC
Q2 2023Aug 11, 202310$3.24MState Street SPDR S&P Regional Banking ETFState Street Utilities Select Sector SPDR ETFState Street Industrial Select Sector SPDR ETFvs. Q1 2023SEC
Q1 2023Jun 23, 20239$6.11MCPNGFERGICLRvs. Q4 2022SEC
Q4 2022Feb 13, 2023Amended2$4.64MState Street SPDR S&P Biotech ETFSBCFvs. Q3 2022SEC
Q3 2022Nov 8, 20224$5.36MState Street SPDR S&P Biotech ETFCPNGFSLRvs. Q2 2022SEC
Q2 2022Aug 9, 20221$4.46MState Street SPDR S&P Biotech ETFvs. Q1 2022SEC
Q1 2022May 31, 2022Amended18$11.9MLINVanEck Semiconductor ETFABNBvs. Q4 2021SEC
Q4 2021Jan 27, 20222$527.0KCITCPvs. Q3 2021SEC
Q3 2021Oct 29, 20214$11.5MiShares TrARK Innovation ETFRRXvs. Q2 2021SEC
Q2 2021Aug 10, 20211$3.71MPRAHvs. Q1 2021SEC
Q1 2021May 7, 202115$7.32MState Street SPDR S&P Regional Banking ETFInvesco Exch Traded FD Tr IIPCG–SEC